Skip to content
Screener

Odyssey Therapeutics ODTX EBITDA

EBITDA at other companies

Thor Industries logo
Thor IndustriesTHO
$189.77M-9.9%
Ambarella logo
AmbarellaAMBA
-$13.05M+31.7%
PVH logo
PVHPVH
$186.9M+171%
Brookdale Senior Living logo
Brookdale Senior LivingBKD
$128.72M+3.7%
Academy Sports and Outdoors logo
Academy Sports and OutdoorsASO
$105.41M+6.0%
Helios Technologies logo
Helios TechnologiesHLIO
$45M+36.4%

Other financials

Income statement

See full
Revenue--100%
Operating income-$55.5M-32.3%
Net income-$52.8M-28.0%
EPS (diluted)-$1.74+94.1%

Balance sheet

See full
Cash & equivalents$82.0M-49.7%
Total debt$24.8M+8,175%
Total equity$421.2M+197%
Total assets$483.9M—

Cash flow

See full
Operating cash flow-$34.5M-0.7%
CapEx$186.0K+541%
Free cash flow-$34.7M-1.2%

Valuation

See full
Market cap$1B+27.8%
Enterprise value$946.17M—
P/S348.8×—

Profitability

See full
Operating margin-6,129%—
Net margin-5,934%—
FCF margin-5,203.9%—

Returns & leverage

See full
Return on equity-8,434.8%—
Debt / equity0.1×—
Current ratio11.4×—

Where this comes from

Calculated from Odyssey Therapeutics’s reported figures.

−$55.5Mebit+
$1.0MDepreciation Depletion & Amortization
=-$54.43M

The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335822

FAQ

What is Odyssey Therapeutics's EBITDA?
Odyssey Therapeutics (ODTX) reported EBITDA of -$54.43M in Q2 2026.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Odyssey Therapeutics's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude